英文名称 | Anlotinib Dihydrochloride (AL3818 Dihydrochloride); Anlotinib 2HCl |
---|---|
中文名称 | 盐酸安罗替尼; 安罗替尼盐酸盐 |
CAS号 | 1360460-82-7 |
分子式 | C23H24Cl2FN3O3 |
分子量 | 480.36 |
外观 | Light yellow to yellow powder |
英文名称 | Anlotinib Dihydrochloride (AL3818 Dihydrochloride); Anlotinib 2HCl |
---|---|
中文名称 | 盐酸安罗替尼; 安罗替尼盐酸盐 |
CAS号 | 1360460-82-7 |
分子式 | C23H24Cl2FN3O3 |
分子量 | 480.36 |
外观 | Light yellow to yellow powder |
Anlotinib, also known as AL3818 and Catequentinib, is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, anlotininib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.